Form D · Pharmaceuticals
VACCINEX, INC.
Rochester, NY · CIK 0001205922
Offering snapshot reported Sep 27, 2024 · SEC filing
- Reported sold
- $200K Offering amount: $9.22M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 18, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 27, 2024 | Initial | $200,155 | No comparison | 8 | SEC filing |
| Apr 12, 2024 | Initial | $0 | No comparison | 4 | SEC filing |
| Apr 12, 2024 | Initial | $1,240,737 | No comparison | 3 | SEC filing |
| Apr 12, 2024 | Initial | $1,750,000 | No comparison | 1 | SEC filing |
| Sep 16, 2020 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Aug 11, 2020 | Initial | $8,000,000 | No comparison | 1 | SEC filing |
| Jul 15, 2020 | Initial | $4,000,000 | No comparison | 1 | SEC filing |
| Feb 3, 2020 | Initial | $7,474,986 | No comparison | 5 | SEC filing |
| Aug 14, 2019 | Initial | $13,799,915 | No comparison | 5 | SEC filing |
| Jul 7, 2017 | Initial | $6,000,000 | No comparison | 1 | SEC filing |
| May 9, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 9, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $8.76K
- Finders' fees
- $0
- Form D file number
- 021-525279
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Roth Capital Partners, LLC | 15407 |
Source: Form D, filed Sep 27, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chrystyna Bedrij Stecyk | Director |
| Alejandro M. Berlin | Director |
| Steven P. Cobourn | Executive |
| Alan L. Crane | Director |
| Elizabeth Evans | Executive |
| Jacob B. Frieberg | Director |
| Albert D. Friedberg | Director |
| J. Jeffrey Goater | Director |
| J. Jeffrey Goater | Director |
| John E. Leonard | Executive |
| Bala S. Manian | Director |
| Bala S. Manian Ph.D. | Director |
| Bala S. Manian, Ph.D. | Director |
| Scott E. Royer | Executive |
| Jill Sanchez | Executive |
| Ernest S. Smith | Executive |
| Ernest S. Smith Ph.D. | Executive |
| Ernest S. Smith, Ph.D. | Executive |
| Gerald E. Van Strydonck | Director |
| Raymond E. Watkins | Executive |
| Barbara Yanni | Director |
| Barbara Yannni | Director |
| Maurice Zauderer | Director, Executive |
| Maurice Zauderer, Ph.D. | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1895 Mount Hope Avenue
Rochester, NY, 14620
Rochester, NY, 14620